The prevalence of symptomatic childhood venous thromboembolism increases among adolescents. The occurrence of nonhereditary prothrombotic risk factors, e.g. oral contraceptive pills, often prescribed to adolescent females for various indications, such as tobacco use, obesity and hypertension may trigger symptomatic thrombosis, especially in carriers of genetic thrombophilia traits. On the other hand, heavy menstrual bleeding is a common clinical problem of young adolescent women. A proper diagnostic workup of these women may enable physicians to detect and treat congenital bleeding disorders, e.g. von Willebrand disease, presenting with menorrhagia. The challenges of diagnosis and treatment of either thrombosis or bleeding disorders in young adults will be discussed in this review.

Keywords:
Adolescents, Menorrhagia, Thrombophilia, Venous thromboembolism, Von Willebrand disease
1.
Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D: Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994;83:1251-1257.
2.
Van Ommen CH, Heijboer H, Büller HR, Hirasing RA, Heijmans HS, Peters M: Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr 2001;139:676-681.
3.
Schmidt B, Andrew M: Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995;96:939-943.
4.
Journeycake JM, Buchanan GR: Thrombotic complications of central venous catheters in children. Curr Opin Hematol 2003;10:369-374.
5.
Revel-Vilk S: Central venous line-related thrombosis in children. Acta Haematol 2006;115:201-206.
6.
Goldenberg NA: Long-term outcomes of venous thrombosis in children. Curr Opin Hematol 2005;12:370-376.
7.
Goldenberg NA, Donadini MP, Kahn SR, Crowther M, Kenet G, Nowak-Gottl U, Manco-Johnson MJ: Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica 2010;95:1952-1959.
8.
Kristjansson AL, Sigfusdottir ID, Allegrante JP: Adolescent substance use and peer use: a multilevel analysis of cross-sectional population data. Subst Abuse Treat Prev Policy 2013;8:27.
9.
Huang DY, Lanza HI, Anglin MD: Assocation between adolescent substance use and obesity in young adulthood: a group-based dual trajectory analysis. Addict Behav 2013;38:2653-2660.
10.
Gomes MP, Deitcher SR: Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med 2004;164:1965.
11.
Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR: Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997;349:83.
12.
Tans G, Bouma BN, Buller HE, Rosing J: Changes of hemostatic variables during oral contraceptive use. Semin Vasc Med 2003;3:61.
13.
Pillai P, Bonny AE, O'Brien SH: Contraception-related venous thromboembolism in a pediatric institution. J Pediatr Adolesc Gynecol 2013;26:186-188.
14.
Centers for Disease Control and Prevention: Sexual experience and contraceptive use among female teens - United States, 1995, 2002, and 2006-2010. MMWR Morb Mortal Wkly Rep 2012;61:297-301.
15.
Miller MK, Pickett M, Leisner K, Sherman AK, Humiston SG: Sexual health behaviors, preferences for care, and use of health services among adolescents in pediatric emergency departments. Pediatr Emerg Care 2013;29:907-911.
16.
Young G, Albisetti M, Bonduel M, Brandao L, Chan A, Friedrichs F, Goldenberg NA, Grabowski E, Heller C, Journeycake J, Kenet G, Krumpel A, Kurnik K, Lubetsky A, Male C, Manco-Johnson M, Mathew P, Monagle P, Van Ommen H, Simioni P, Svirin P, Tormene D, Nowak-Gottl U: Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation 2008;118:1373-1382.
17.
Kenet G, Lutkhoff LK, Albisetti M, Bernard T, Bonduel M, Brandao L, Chabrier S, Chan A, De Veber G, Fiedler B, Fullerton HJ, Goldenberg NA, Grabowski E, Gunther G, Heller C, Holzhauer S, Iorio A, Journeycake J, Junker R, Kirkham FJ, Jurnik K, Lynch JK, Male C, Manco-Johnson M, Mesters R, Monagle P, van Ommen CH, Raffini L, Rostasy K, Simioni P, Strater RD, Young G, Nowak-Gottle U: Impact of inherited thrombophilia on arterial ischemic stroke and cerebral sinovenous thrombosis in children: a systematic review and meta-analysis of observational studies. Circulation 2010;121:1838-1847.
18.
Kenet G, Aronis S, Berkun Y, Bonduel M, Chan A, Goldenberg NA, Holzhauer S, Iorio A, Journeycake J, Junker R, Male C, Manco-Hohnson M, Massicotte P, Mesters R, Monagle P, van Ommen H, Rafini L, Simioni P, Young G, Nowak-Gottle U: Impact of persistent antiphospholipid antibodies on symptomatic thromboembolism in children: a systematic review and meta-analysis (observational studies). Semin Thromb Haemost 2011;37:802-809.
19.
Monagle P, Chalmers E, Chan A, De Veber G, Kirkham F, Massicotte P, Michelson AD; American College of Chest Physicians: Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed). Chest 2008;133:887S-968S.
20.
Bidlingmaier C, Kenet G, Kurnik K, Mathew P, Manner D, Mitchell L, Krumpel A, Nowak-Gottle U: Safety and efficacy of low molecular weight heparin in children: a systematic review of the literature and meta-analysis of single arm studies. Semin Thromb Haemost 2011;37:814-825.
21.
Nowak-Gottl U, Dietrich K, Schaffranek D, Eldin NS, Yasui Y, Geisen C, Mitchell G: In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes. Blood 2010;116:5789-5790.
22.
Young G: New anticoagulants in children: a review of recent studies and a look to the future. Thromb Res 2011;127:70-74.
23.
James AH, Kouides PA, Abdul-Kadir R, Edlund M, Federici AB, Halimeh S, Kamphuisen PW, Konkle BA, Martinez-Perez O, McLintock C, Peyvandi F, Winikoff R: Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obst Gynecol 2009;201:12.e1-e8.
24.
Nur Azura AG, Sanci L, Moore E, Grover S: The quality of life of adolescents with menstrual problems. J Pediatr Adolesc Gynecol 2013;26:102-108.
25.
Pai M, Chan A, Barr R: How I manage heavy menstrual bleeding. Br J Haematol 2013;162:721-729.
26.
Ahuja SP, Hetweck SP: Overview of bleeding disorders in adolescent females with menorrhagia. J Ped Adolesc Gynecol 2010;23(suppl):S15-S21.
27.
Halimeh S: Menorrhagia and bleeding disorders in adolescent females. Hemostaseologie 2012;32:45-50.
28.
Hedlund Treutiger I, Ravel Vilk S, Blanchette VS, Curtin JA, Lilicrap D, Rand ML: Reliability and reproducibility of classification of children as ‘bleeders' versus ‘non-bleeders' using a questionnaire for significant muco-cutaneous bleeding. J Pediatr Hematol Oncol 2004;26:488-491.
29.
Kadir RA, Davies J: Hemostatic disorders in women. J Thromb Haemost 2013;11(suppl 1):170-179.
30.
Von Willebrand E: Hereditary pseudohemophilia. Finska Läkarsällskapets Handl 1926;67:7-112.
31.
Byams VR, Anderson BL, Grant AM, Atrash H, Schulkin J: Evaluation of bleeding disorders in women with menorrhagia: a survey of obstetrician-gynecologists. J Obstet Gynecol 2012;207:269.e1-e5.
32.
James AH, Kouides PA, Abdul-Kadir RA, Dietrich JE, Edlund M, Federici AB, Halimeh S, Kamphuisen PW, Lee CA, Martinez-Perez O, McLintock O, Peyvandi F, Philipp C, Wilkinson J, Winikoff R: Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel. Eur J Obstet Gynecol 2011;158:124-134.
33.
Lethagen S, Hillarp A, Ekolm C, Mattson E, Halden C, Friberg B: Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes. Thromb Haemost 2008;99:1013-1018.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.